Stock Price & Analysis

Based on the recent technical analysis and fundamental data, EMR stock shows mixed signals:

Technical Analysis:

• Current price: $122.35 in pre-market trading, up 0.41% [Relevant Data]
• RSI-14 at 40.73 indicates neutral territory but approaching oversold conditions
• MACD shows bearish momentum with -0.66 value and -0.52 histogram
• Stock is trading below its 20-day SMA ($126.69), suggesting short-term weakness

Recent Developments:

• Emerson announced acquisition of remaining AspenTech shares for $7.2 billion, which CEO called "a key milestone in portfolio transformation"
• The company has been actively reshaping its portfolio to focus on automation and software capabilities
• Strong Q1 FY2025 performance with free cash flow improvements and margin expansion

Fundamental Strength:

• Dividend King status with 67 consecutive years of dividend increases
• Management guides 4-7% organic revenue growth and double-digit earnings growth long-term
• Comfortable dividend payout ratio of 35%

Analyst Perspective:

• Jefferies initiated Buy rating with $160 price target (25% upside potential)
• High rating of 81% using Multi-Factor Investor model

Recommendation: HOLD

• While EMR shows strong long-term fundamentals and strategic positioning in automation, current technical indicators suggest waiting for a better entry point
• Consider accumulating on pullbacks closer to support levels around $120

Based on the provided data and recent market developments, here's a comprehensive price prediction analysis for EMR stock in 2025:

Technical Analysis

The current technical indicators show EMR is in a consolidation phase around $123-124 level, with RSI at 40.73 indicating neutral momentum. The MACD shows a bearish divergence with -0.66, suggesting some near-term weakness.

Fundamental Drivers

Recent developments supporting the price prediction:

• Q1 FY25 results beat EPS expectations ($1.38 vs $1.28)
• Management revised FY25 sales growth outlook down to 1.5-3.5% from 3.5-5.5%
• Maintained FY25 adjusted EPS guidance of $5.85-6.05
• Planning $3.2B shareholder returns through $2.0B buybacks and $1.2B dividends

Analyst Consensus

According to recent analyst coverage:

• 16 Strong Buy ratings
• 1 Moderate Buy
• 5 Hold ratings
• 1 Moderate Sell
• Mean price target: $139.96 (14.4% upside)
• Street high target: $160 (30.8% upside)

2025 Price Prediction

Based on the technical and fundamental analysis, here are the three scenarios for EMR stock price by end of 2025:

1. Base Case (60% probability): $135-140

• Driven by continued execution on automation strategy
• Achievement of FY25 guidance
• Successful integration of AspenTech acquisition

2. Bull Case (25% probability): $150-160

• Stronger than expected margin expansion
• Acceleration in discrete automation recovery
• Higher synergies from acquisitions

3. Bear Case (15% probability): $110-115

• Global economic slowdown impacting industrial demand
• Integration challenges with acquisitions
• Margin pressure from competitive environment

The most likely scenario points to EMR reaching $135-140 by end of 2025, supported by the company's strong market position in industrial automation and consistent execution track record.

The S1 support level for EMR Stock is $119.61 ,The R1 resistant level for EMR Stock is $126.37.

As of the end of day on 2025-02-26, the price of EMR Stock was $120.61.

The target price for EMR Stock according to analyst rating is 142.33, with the highest price target at 160.00 and the lowest at 112.00. Analysts have a Moderate Buy rating on EMR Stock overall.

The market cap of EMR is $67.5B.

Based on the provided data and recent market trends, here's a concise analysis of EMR's valuation:

EMR appears to be fairly valued at current levels, considering several key factors:

Valuation Metrics: The current P/E ratio of 25.96x is higher than the 2022 level of 13.51x, indicating some premium valuation. However, this is justified by the company's strong earnings growth and strategic positioning.

Growth & Profitability: Despite revenue declining from $19.6B to $15.2B in FY2023, net income significantly increased from $3.2B to $13.2B, demonstrating improved operational efficiency. The gross margin also improved from 39.9% to 45.8%.

Market Position: EMR has received an 81% rating using the Multi-Factor Investor model, suggesting strong fundamentals. The company's recent 43% acquisition of Aspen Technology positions it as a leader in industrial automation.

Technical Signals: Current RSI at 40.73 indicates neutral momentum, while trading between key Fibonacci levels of R1 ($127.42) and S1 ($121.81) suggests a balanced price position.

The stock's current price of $122.35 appears to reflect its fair value, considering both its growth prospects and market position.

Emerson Electric Co. is a global technology and software company. The Company is a global manufacturer that combines technology and engineering to provide advanced solutions to its customers. The Company operates through six segments under two business groups, such as Intelligent Devices, and Software and Control. Its Intelligent Devices business includes Final Control, Measurement & Analytical, Discrete Automation, and Safety & Productivity. The Software and Control business include Control Systems & Software, AspenTech, and Test & Measurement. Final Control segment includes valves, and actuators & regulators product offerings. Measurement & Analytical segment includes liquid analysis, gas analysis, tank gauging system and others. Discrete Automation segment includes industrial solutions product offerings. Safety & Productivity segment includes tools and home products. AspenTech segment provides asset optimization software that enables industrial manufacturers to maintain operations.

Based on the available data and market analysis, EMR stock is projected to reach approximately $185-195 by 2030, driven by its strong position in industrial automation and software solutions following the successful integration of Aspen Technology. The company's consistent earnings growth, with analysts expecting 7.7% EPS growth, coupled with its strategic focus on software-defined control and expansion into high-growth markets, supports this long-term price target. The stock's robust technical indicators and positive analyst sentiment, with 16 "Strong Buy" ratings, further reinforce the bullish outlook for EMR's long-term growth trajectory.

EMR has a total of 67000 employees.